Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia

NCT01259713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Fungal Disease

Interventions

DRUG: Liposomal amphotericin B
DRUG: Placebo

Sponsor

Gilead Sciences